DnB NOR Asset Management AS »

Lenz Therapeutics shares owned by DnB NOR Asset Management AS

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by DnB NOR Asset Management AS from 13F filings

Historical chart of DnB NOR Asset Management AS investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by DnB NOR Asset Management AS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by DnB NOR Asset Management AS

Quarter filed Position value Share count Share price at filing
2025-12-31 $307k 19k 16.00

More positions owned by DnB NOR Asset Management AS

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Mastercard Cl A (MA)
Visa Com Cl A (V)
Atlassian Corp Cl A (TEAM)
Broadcom (AVGO)
salesforce (CRM)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Check Point Software Tech LT Ord (CHKP)
Alphabet Cap Stk Cl C (GOOG)

View all positions for DnB NOR Asset Management AS

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
UBS Group
BlackRock
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Adage Capital Partners GP
Intrinsic Edge Capital Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops
Standard Life Aberdeen

View all funds holding Lenz Therapeutics